Featured Research

from universities, journals, and other organizations

Researchers Begin Tests On Next Generation Of Retinal Implant

Date:
March 21, 2007
Source:
University of Southern California
Summary:
Researchers at the University of Southern California are moving into their next phase of an artificial retinal implant project.

Patients who have gone blind are a step closer to perhaps one day regaining some of their sight. Researchers at the University of Southern California (USC), Doheny Eye Institute, announced today the next step in their efforts to advance technology that will hopefully help patients with retinitis pigmentosa and macular degeneration regain some vision using an implanted artificial retina.

The announcement by Mark Humayun, M.D., Ph.D., professor of ophthalmology at the Doheny Eye Institute, Keck School of Medicine of USC came at a press conference at the American Association for the Advancement of Science (AAAS) annual meeting in San Francisco.

The Food and Drug Administration (FDA) recently approved an Investigational Device Exemption (IDE) to conduct a clinical study of the new device- dubbed the Argus II Retinal Prosthesis System.

The implantable technology is a collaborative effort between USC and Second Sight Medical Products, which manufactures the implant. The Argus II is the second generation of an electronic retinal implant designed for the treatment of blindness due to retinitis pigmentosa (RP), a group of inherited eye diseases that affect the retina. RP causes the degeneration of photoreceptor cells in the retina, which capture and process light helping individuals to see. As these cells degenerate, patients experience progressive vision loss. The Argus device is essentially designed to take the place of the photoreceptors.

"The first phase of our implant work began in 2002," says Humayun. "We have successfully implanted six patients in the trial and we have found that the devices are indeed electrically conducting and can be used by patients to detect light or even to distinguish between objects such as a cup or plate."

While the first generation of implants contained 16 electrodes laid out on an array, the Argus II is designed with 60 electrodes, which is intended to allow for higher resolution images.

The new device is also approximately one quarter the size of the original, reducing surgery and recovery times.

The array is attached to the retina and used in conjunction with an external camera and video processing system to provide a rudimentary form of sight to implanted subjects.

The clinical trial of the first generation of implants continues at the Doheny Eye Institute at USC. All six previously blind patients in the first trial have been able to detect light, identify objects in their environment and even perceive motion after implantation with the first generation device.

The device, ultimately, may be used for the millions of people suffering from age-related macular degeneration, or AMD. In fact, Humayun says, there are 25 million people around the world, including 6 million in the United States alone, who have been blinded, or are severely visually impaired, due to diseases like RP and AMD.

By 2020, that figure is expected to double, creating a virtual vision-loss epidemic.

Both AMD and RP destroy vision by annihilating the retinal cells that allow light to be translated into recognizable images.

"Perhaps what we're most excited about in this next study," says Humayun, "is, similar to the first generation Second Sight device, we will be able to test the new device with patients at their homes, churches, schools and similar locations. The importance of this work is going to be reflected in how well this helps them regain some of their lost vision."

The current study will include patients over 50 years of age who have RP or AMD and who have had previous functional vision.

This study is supported by the Department of Energy, the National Science Foundation, National Eye Institute/NIH, Research to Prevent Blindness, the W.M. Keck Foundation and the Albaugh Family Trust.


Story Source:

The above story is based on materials provided by University of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University of Southern California. "Researchers Begin Tests On Next Generation Of Retinal Implant." ScienceDaily. ScienceDaily, 21 March 2007. <www.sciencedaily.com/releases/2007/03/070319180027.htm>.
University of Southern California. (2007, March 21). Researchers Begin Tests On Next Generation Of Retinal Implant. ScienceDaily. Retrieved April 19, 2014 from www.sciencedaily.com/releases/2007/03/070319180027.htm
University of Southern California. "Researchers Begin Tests On Next Generation Of Retinal Implant." ScienceDaily. www.sciencedaily.com/releases/2007/03/070319180027.htm (accessed April 19, 2014).

Share This



More Health & Medicine News

Saturday, April 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Nine-Month-Old Baby Can't Open His Mouth

Nine-Month-Old Baby Can't Open His Mouth

Newsy (Apr. 19, 2014) Nine-month-old Wyatt Scott was born with a rare disorder called congenital trismus, which prevents him from opening his mouth. Video provided by Newsy
Powered by NewsLook.com
'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins